Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
PR Newswire
Report Store
UsernamePublicRestriction
Tags:

Genomic Patent Exclusivity Tackled By NIH “Best Practices” Draft Guidance

This article was originally published in The Gray Sheet

  • News

Executive Summary

NIH is floating a three-page draft guidance on best practices for the licensing of genomic inventions

You may also be interested in...



NIH Genomics Licensing Policy Guidance Debated By Advocacy Groups

The National Institutes of Health expects to publish by year-end a "best practices" document for the licensing of genomic inventions

NIH Genomics Licensing Policy Guidance Debated By Advocacy Groups

The National Institutes of Health expects to publish by year-end a "best practices" document for the licensing of genomic inventions

Pharmacogenomic Progress Hinges On Strong Pharma Backing – Consultant

Reference labs developing less costly "homebrew" tests could supplant diagnostic firms as the vehicle for commercializing pharmacogenomic tests, consultant Richard Barker told attendees at the IBC Dx/Rx Summit March 9 in Reston, Va
Table

View full table

Related Content

Medtech Insight Medtech Insight
Tags:
UsernamePublicRestriction

Register

MT020047

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By